BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan · Delayed Price · Currency is JPY 65.00
-1.00 (-1.52%)
At close: Apr 17, 2026
TYO:4594 Market Cap
TYO:4594 has a market cap or net worth of 8.78 billion as of April 17, 2026. Its market cap has increased by 113.60% in one year.
Market Cap
8.78B
Enterprise Value
7.84B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.00
Market Cap Chart
Since October 22, 2015, TYO:4594's market cap has decreased from 13.23B to 8.78B, a decrease of -33.62%. That is a compound annual growth rate of -3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 8.78B | 64.28% |
| Dec 30, 2025 | 5.35B | 37.06% |
| Dec 30, 2024 | 3.90B | -28.70% |
| Dec 29, 2023 | 5.47B | -13.00% |
| Dec 30, 2022 | 6.29B | 7.22% |
| Dec 30, 2021 | 5.87B | -35.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 11.13B |
| Kubota Pharmaceutical Holdings | 10.85B |
| K Pharma,Inc. | 8.81B |
| Carna Biosciences | 8.29B |
| CellSource | 8.08B |
| MEDINET | 7.99B |
| StemCell Institute | 7.95B |
| ADR120S | 7.36B |